
AI-generated summary
The National Association of Statutory Health Insurance Funds represents the interests of those with statutory health insurance in Germany. There are currently discussions about a fairer distribution of doctor's appointments between those with statutory and private insurance, as those with statutory health insurance often experience longer waiting times.
According to the umbrella association of statutory health insurance companies, those with statutory health insurance should be better off when it comes to arranging doctor's appointments. “We have to organize access to outpatient care so that appointments are made based on medical needs and not based on how someone is insured,” said the CEO of the National Association of Statutory Health Insurance Funds, Oliver Blatt, to Funke Medien.
75 million people are legally insured and thus finance the vast majority of medical fees. Nevertheless, they are often disadvantaged when it comes to making appointments. This is a “blatant injustice.” (Read the current SPIEGEL cover story “Second Class People.”)
The umbrella association had previously explained that in order to achieve justice, a daily updated platform was needed in which all practices posted a fixed proportion of their appointments. And then you should no longer be allowed to ask whether you are legally or privately insured.
Chancellor Friedrich Merz (CDU) said almost a month ago that if the impression becomes that those with private insurance receive every benefit immediately and those with statutory health insurance wait weeks and months, that would be "a problem of justice." GKV boss Blatt now said that doctors should continue to treat private patients, but should not automatically give them priority. “A person with statutory health insurance should not have to wait two weeks longer just for that reason.”
GKV boss against the concept of two-class medicine
Blatt said he doesn't believe in the term two-class medicine. "In the hospital and by the vast majority of doctors, those with statutory health insurance are treated just as well as private patients, and in some cases the billing is even easier for them," he said. The unequal treatment is particularly evident in the waiting times for doctor's appointments.
In SPIEGEL, the head of the Techniker Krankenkasse, Jens Baas, spoke out in favor of restructuring the dual system with statutory and private health insurance. Private and statutory health insurance should be abolished. The best of both worlds should then be used in a new system.
AI outlook — possibilities, not facts
The federal government will present a draft law to reform the allocation of medical appointments within the next few months.
Likely · Within months
The discussion about abolishing the dual system of statutory and private health insurance will become more intense in the coming weeks.
Possible · Within weeks

Due to the impending shortage of general practitioners in Germany and Brandenburg, the Medical University of Lausitz has started operations in Cottbus with its first students. A new country doctor quota should provide long-term relief.

In the Malteser practice in Stuttgart, more and more people without health insurance are seeking medical help. In addition to refugees and homeless people, pensioners and self-employed people who fell out of the system due to contribution debts are increasingly affected.
A study published in the journal Nature Medicine describes menopause as a “physiological cliff.” Researchers evaluated 300 million laboratory data and found that metabolism, organ functions and hormones were already changing abruptly years before.

Former Olympic sprinter Beth Dobbin suffers from the chronic multisystem disease ME/CFS. She reports on the severity of the symptoms, the lack of recognition of the disease and the lack of effective treatment options.

Health economist Boris Augurzky criticizes the contribution rate stabilization law as a short-term shift in burdens to the detriment of hospitals and calls for structural reforms, reductions in bureaucracy and a sensible approach to the sugar tax.

An EMA committee has recommended approval of Eli Lilly's Foundayo weight loss pill for weight control and type 2 diabetes treatment. After Wegovy, it would be the second oral drug of its kind in the EU.